JP2023526449A5 - - Google Patents

Info

Publication number
JP2023526449A5
JP2023526449A5 JP2022570566A JP2022570566A JP2023526449A5 JP 2023526449 A5 JP2023526449 A5 JP 2023526449A5 JP 2022570566 A JP2022570566 A JP 2022570566A JP 2022570566 A JP2022570566 A JP 2022570566A JP 2023526449 A5 JP2023526449 A5 JP 2023526449A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
sequence
park2
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022570566A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526449A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033758 external-priority patent/WO2021237158A1/en
Publication of JP2023526449A publication Critical patent/JP2023526449A/ja
Publication of JP2023526449A5 publication Critical patent/JP2023526449A5/ja
Priority to JP2026058789A priority Critical patent/JP2026120585A/ja
Pending legal-status Critical Current

Links

JP2022570566A 2020-05-21 2021-05-21 パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達 Pending JP2023526449A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026058789A JP2026120585A (ja) 2020-05-21 2026-03-31 パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063028335P 2020-05-21 2020-05-21
US63/028,335 2020-05-21
PCT/US2021/033758 WO2021237158A1 (en) 2020-05-21 2021-05-21 Gene therapy delivery of parkin mutants having increased activity to treat parkinson's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026058789A Division JP2026120585A (ja) 2020-05-21 2026-03-31 パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達

Publications (2)

Publication Number Publication Date
JP2023526449A JP2023526449A (ja) 2023-06-21
JP2023526449A5 true JP2023526449A5 (cg-RX-API-DMAC7.html) 2024-04-23

Family

ID=78707645

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022570566A Pending JP2023526449A (ja) 2020-05-21 2021-05-21 パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達
JP2026058789A Pending JP2026120585A (ja) 2020-05-21 2026-03-31 パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026058789A Pending JP2026120585A (ja) 2020-05-21 2026-03-31 パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達

Country Status (6)

Country Link
US (2) US12133897B2 (cg-RX-API-DMAC7.html)
EP (1) EP4153760A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023526449A (cg-RX-API-DMAC7.html)
AU (1) AU2021273979A1 (cg-RX-API-DMAC7.html)
CA (1) CA3179402A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021237158A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL278213B2 (en) 2018-04-27 2026-04-01 Rocket Pharmaceuticals Ltd A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
JP2023526449A (ja) 2020-05-21 2023-06-21 ニスノバイオ ジーティー,エルエルシー パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2872581C (fr) * 1998-11-19 2018-04-10 Aventis Pharma S.A. Mutations du gene de la parkine, compositions, methodes et utilisations
EP2345722A1 (fr) * 1998-11-19 2011-07-20 Aventis Pharma S.A. Mutations du gêne de la parkine, compositions, méthodes et utilisations
US6855314B1 (en) 2000-03-22 2005-02-15 The United States Of America As Represented By The Department Of Health And Human Services AAV5 vector for transducing brain cells and lung cells
WO2009026116A2 (en) * 2007-08-16 2009-02-26 Genizon Biosciences, Inc. Genemap of the human genes associated with longevity
US9169494B2 (en) * 2010-01-12 2015-10-27 The University Of North Carolina At Chapel Hill Restrictive inverted terminal repeats for viral vectors
US8603994B2 (en) * 2010-11-11 2013-12-10 Valted, Llc Transcriptional repression leading to Parkinson's disease
WO2014179755A2 (en) * 2013-05-02 2014-11-06 E3X Bio Method for identifying modulators of ubiquitin ligases
WO2017191274A2 (en) * 2016-05-04 2017-11-09 Curevac Ag Rna encoding a therapeutic protein
IL278213B2 (en) 2018-04-27 2026-04-01 Rocket Pharmaceuticals Ltd A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
CA3115251A1 (en) 2018-10-05 2020-04-09 University Of Massachusetts Raav vectors for the treatment of gm1 and gm2 gangliosidosis
JP2023526449A (ja) 2020-05-21 2023-06-21 ニスノバイオ ジーティー,エルエルシー パーキンソン病を治療するための、増加した活性を有するパーキン変異体の遺伝子治療送達

Similar Documents

Publication Publication Date Title
Collier et al. Therapeutic potential of nerve growth factors in Parkinson’s disease
US7588757B2 (en) Methods of treating Parkinson's disease using recombinant adeno-associated virus virions
Simonato et al. Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors
MX2010012592A (es) Vectores para la administracion de proteinas sensibles a la luz y metodos de uso de las mismas.
KR20240110849A (ko) Aadc/gdnf 폴리뉴클레오티드 및 이의 파킨슨병 치료에 있어서의 용도
IL324039A (en) Compositions and methods for the treatment of disorders related to cdkl5 deficiency
JP2022536338A5 (cg-RX-API-DMAC7.html)
JP2025188191A (ja) パーキンソン病を治療するための方法
US20230250404A1 (en) Recombinant dgkk gene for fragile x syndrome gene therapy
JP2005507927A5 (cg-RX-API-DMAC7.html)
CN119351409A (zh) 优化的编码脑源性神经营养因子的多核苷酸及其应用
Kim et al. AAV-GAD gene for rat models of neuropathic pain and Parkinson’s disease
Verhaagen et al. Gene therapy for spinal cord injury
CA2464887A1 (en) Methods and compositions for treating parkinson's disease
CN119971081B (zh) 用于治疗智力障碍的组合物、其应用以及药物筛选方法
EA051580B1 (ru) Способы лечения болезни паркинсона
CN115135347A (zh) 治疗帕金森病的方法
WO2024147114A1 (en) Compositions and methods for treating parkinson's disease
WO2026021447A1 (zh) 一种M4Di变体以及其治疗疼痛的应用
RU2021139251A (ru) Композиции аденоассоциированного вируса для переноса гена arsa и способы их применения
CN121866334A (zh) 用于调控神经元和星形胶质细胞中的基因表达以评估和/或治疗slc6a1相关的病症的人工表达构建体
Okada et al. Shin-ichi Muramatsu, Lijun Wang,*† Kunihiko Ikeguchi, Ken-ichi Fujimoto
CN118725046A (zh) 具有经修饰的腺相关病毒(aav)衣壳多肽的重组aav
CN116670160A (zh) Dlx2载体
CN116782921A (zh) Neurod1组合载体